Arden Trust Co: VTEB position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Arden Trust Co on VTEB, newest first. How the timeline and the estimate are built.
Arden Trust Co held 148,029 VTEB shares at 2024-06-30 per its 13F-HR filed 2024-07-09.
the latest 13F is the newest step
- period ended2024-06-3013F 148,029 sharesChange vs previous 13F +3,874 shares
1.04% of the 13F portfolio, value $7,417,732.
13F-HR 0001780607-24-000003 filed by Arden Trust Co
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-03-3113F 144,155 sharesChange vs previous 13F +7,324 shares
1.02% of the 13F portfolio, value $7,294,242.
13F-HR 0001780607-24-000002 filed by Arden Trust Co
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2023-12-3113F 136,831 sharesChange vs previous 13F +5,258 shares
1.03% of the 13F portfolio, value $6,985,225.
13F-HR 0001780607-24-000001 filed by Arden Trust Co
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2023-09-3013F 131,573 sharesChange vs previous 13F +45,110 shares
1.05% of the 13F portfolio, value $6,328,662.
13F-HR 0001780607-23-000005 filed by Arden Trust Co
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2023-06-3013F 86,463 sharesChange vs previous 13F +62,176 shares
0.71% of the 13F portfolio, value $4,342,000.
13F-HR 0001780607-23-000004 filed by Arden Trust Co
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2023-03-3113F 24,287 sharesChange vs previous 13F not available
0.22% of the 13F portfolio, value $1,230,000.
13F-HR 0001780607-23-000003 filed by Arden Trust Co
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).